• Dr. Domb!

    Thanks a lot for getting my hip right. Looking forward to a full recovery and a great season. Thanks again for everything.

    Corey WoottonChicago Bears and Detroit Lions
  • Thank you for all that you have done for me and the team. My hip feels so much better, and because of you I'm pain free.
    Sylvia Fowles WNBA Finals MVP, 2-time Olympic Gold Medalist
  • Thank you for working your magic! You're the best!
    Zakiya BywatersChicago Red Stars, National Women's Soccer League
  • Thanks for all the love and positive Energy that was put into my surgery. May the Lord bless you and your family.
    Atari BigbyGreen Bay Packers and San Diego Chargers
  • Dr. Domb, Thanks for fixing me up
    Rashied DavisChicago Bears
  • Huge thank you to Dr. Domb for always taking care of me and getting me back on the court in no time!
    Elena Delle DonneChicago Sky, MVP of the WNBA
  • Dr. Domb! Thanks for taking care of the hip! All the best to you and your staff
    Roosevelt ColvinChicago Bears' All-Decade Defense team
  • Thanks doc for fixing my hip!
    Ryan ChiaveriniWindy City Live Co-Host on ABC7

2014- Domb et al. Outcomes of Hip Arthroscopy in Patients Aged 50 years or Older Compared to a Matched-Pair Control of Patients Aged 30 years or younger. Arthroscopy.

Purpose:Age has been suggested as a negative prognostic factor for hip arthroscopy. The purpose of this study was to compare patient characteristics and outcomes after hip arthroscopy in patients aged 50 years or older with a matched control group of patients aged 30 years or younger at a minimum postoperative follow-up of 2 years.

Methods:Between September 2008 and March 2010, data were prospectively collected on all patients aged 50 years or older undergoing primary hip arthroscopy. Fifty-two patients met our inclusion and matching criteria, of whom all 52 (100%) were available for follow-up at a minimum of 2 years. This cohort was compared with a matched-pair control group of patients aged 30 years or younger who underwent similar procedures.

Results:The mean age of the study group was 54.8 years (range, 50 to 69 years), and that of the control group was 20.3 years (range, 13 to 30 years). The groups were matched at a 1:1 ratio, including 18 male patients (34.6%) and 34 female patients (65.4%) in each group, with a mean follow-up period of 32 months (range, 24 to 54 months). In the younger control group, the score improvement from preoperatively to 2 years' follow-up was 62.9 to 84.2 for the modified Harris Hip Score, 60.5 to 84.2 for the Non-Arthritic Hip Score, 63.1 to 86.5 for the Hip Outcome ScoreeActivities of Daily Living, and 42.2 to 72.7 for the Hip Outcome ScoreeSport-Specific Subscale. In the older study group, the score improvement from preoperatively to 2 years' follow-up was 61.2 to 82.2 for the modified Harris Hip Score, 59.9 to 80.4 for the Non-Arthritic Hip Score, 63.9 to 83 for the Hip Outcome ScoreeActivities of Daily Living, and 41.2 to 64.6 for the Hip Outcome ScoreeSport-Specific Subscale. All improvements in both groups were statistically significant at the 2-year postoperative follow-up (P < .001). There was no significant difference for all patient-reported outcome (PRO) scores at final follow-up between both groups. When we compared the change in PRO scores (D) from preoperatively to 2 years postoperatively, there was no significant difference between both groups. The overall survivorship rate was 98.1% for the younger control group and 82.7% for the older study group.

Conclusions: Survivors aged 50 years or older show similar improvement to patients aged 30 years or younger in PRO and patient satisfaction scores. The 2-year survivorship rate was 98.1% for the younger control group and 82.7% for the older study group. Therefore we believe that hip arthroscopy should be considered a valid treatment option when treating hip pain in patients aged 50 years or older with a Tönnis arthritic grade of 0 or 1. Older patients should be counseled on the possibility of later conversion to total hip arthroplasty. Future work may include development of a decision-making tool to assess for prognosis to better delineate the indications for hip arthroscopy in the older population.

Level of Evidence: Level III, therapeutic case-control study.

Click here to download the complete publication